If youre interested in medical weight loss, were here to answer your questions
Semaglutide is approved for weight and diabetes, and pemvidutide is still investigational
For differential expression testing, the R package DESeq2 (v.1.30.1) was used to identify differentially expressed genes
We extracted the following 30 factors: age, sex, body mass index (BMI), race (Asian, American Indian or Alaska Native, Black or African American, Native Hawaiian or Other Pacific Islander, White, Other Race, unknown), diagnoses (heart failure, ischemic heart diseases, old myocardial infarction, atrial fibrillation and flutter, hypertension, dyslipidemia, chronic kidney disease, cerebral infarction), and medication (be-ta blockers, diuretics, mineralocorticoid receptor antagonists [MRA], angiotensin converting enzyme [ACE] inhibitors, angiotensin II receptor blockers [ARB], sacubitril, statins, metformin, sulfonylureas, sodium-glucose co-transporter 2 [SGLT2] inhibitors, insulin, laboratory (systolic blood pressure, diastolic blood pressure, glomerular filtration rate [GFR], hemoglobin, albumin, LDL cholesterol, hemoglobin A1c [HbA1c])
The practical implication is straightforward: a dose that feels tolerable for a man may be genuinely too much for a woman of equivalent weight